Connect your AI

Revvity RVTY Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Thermo Fisher ScientificTMO

$5.24B+84.4%

DanaherDHR

$0-100%

The Cooper Companies, Inc.COO

$857.7M+14.6%

WAT

Waters CorporationWAT

$3.53B—

Agilent TechnologiesA

$0—

IQVIAIQV

$650M-67.3%

Other financials

Income statement

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt.

The official record: Revvity’s 10-K, filed February 27, 2024, on SEC EDGAR. View the filing →

Ask your AI about Revvity's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Revvity's debt issuance proceeds?: Revvity (RVTY) reported debt issuance proceeds of $0 in Q4 2023.